{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:34:25Z","timestamp":1761237265414},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s10822-005-9012-4","type":"journal-article","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T11:00:39Z","timestamp":1130929239000},"page":"567-583","source":"Crossref","is-referenced-by-count":19,"title":["Prediction of plasma protein binding of drugs using Kier\u2013Hall valence connectivity indices and 4D-fingerprint molecular similarity analyses"],"prefix":"10.1007","volume":"19","author":[{"given":"Jianzhong","family":"Liu","sequence":"first","affiliation":[]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[]},{"given":"Dahua","family":"Pan","sequence":"additional","affiliation":[]},{"given":"Anton J.","family":"Hopfinger","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2005,11,3]]},"reference":[{"key":"9012_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000220395","volume":"10","author":"T.E. Krueger","year":"1965","unstructured":"Krueger T.E., Buenger P., 1965 The role of the therapeutic regimen in dosage design Chemotherapia 10: 61 129","journal-title":"Chemotherapia"},{"key":"9012_CR2","volume-title":"All about Albumin: Biochemistry, Genetics, and Medical Applications","author":"T. Peters","year":"1995","unstructured":"Peters T., All about Albumin: Biochemistry, Genetics, and Medical Applications, Academic Press, San Diego. 1995"},{"key":"9012_CR3","volume-title":"The Pharmacological Basis of Therapeutics","author":"G.A. Goodman","year":"1996","unstructured":"Goodman G.A., The Pharmacological Basis of Therapeutics. 9. McGraw-Hill, New York: 1996","edition":"9"},{"key":"9012_CR4","unstructured":"Holford, N.H.G. and Benet, L.Z., In Katzung, B.G. (Ed.), Basic and Clinical Pharmacology, 7th Edition, Appleton and Lange, Stamford, CT, 1998, pp. 34\u201349"},{"key":"9012_CR5","volume-title":"All about Albumin: Biochemistry Genetics and Medical Applications","author":"P.J. Torres","year":"1996","unstructured":"Torres P.J., 1996 All about Albumin: Biochemistry Genetics and Medical Applications. Academic Press, San Diego"},{"issue":"6","key":"9012_CR6","first-page":"824","volume":"11","author":"G. Sudlow","year":"1975","unstructured":"Sudlow G., Birkett D.J., Wade D.N., 1975 The characterization of two specific drug binding sites on human serum albumin Mol. Pharm. 11(6):824","journal-title":"Mol. Pharm."},{"issue":"6","key":"9012_CR7","first-page":"1052","volume":"12","author":"G. Sudlow","year":"1976","unstructured":"Sudlow G., Birkett D.J., Wade D.N., 1976 Further characterization of specific drug binding sites on human serum albumin Mol. Pharm. 12(6):1052","journal-title":"Mol. Pharm."},{"key":"9012_CR8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/bj3490813","volume":"349","author":"S. Watanbe","year":"2000","unstructured":"Watanbe S., Tanase K.N., Maruyama T., Kragh-Hansen U., Otagiri M., 2000 Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity Biochem. J. 349:813","journal-title":"Biochem. J."},{"key":"9012_CR9","doi-asserted-by":"crossref","first-page":"38731","DOI":"10.1074\/jbc.M005460200","volume":"275","author":"A.A. Bhattacharya","year":"2000","unstructured":"Bhattacharya A.A., Curry S., Franks N.P., 2000 Binding of the general anesthetics propofol and halothane to human serum albumin: high-resolution crystal structures J. Biol. Chem. 275:38731","journal-title":"J. Biol. Chem."},{"key":"9012_CR10","doi-asserted-by":"crossref","first-page":"22804","DOI":"10.1074\/jbc.M100575200","volume":"276","author":"I. Petitpas","year":"2001","unstructured":"Petitpas I., Bhattacharya A.A., Twine S., East M., Curry S., 2001 Crystal structure analysis of warfarin binding to human serum albumin anatomy of drug site I J. Biol. Chem. 276:22804","journal-title":"J. Biol. Chem."},{"key":"9012_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/9783527613083.ch3","volume-title":"Virtual Screening for Bioactive Molecules","author":"J.J. Morris","year":"2000","unstructured":"Morris J.J., Bruneau P.P., 2000 Prediction of physicochemical properties. In: B\u00f6hm H.-J., Schneider G., eds. Virtual Screening for Bioactive Molecules. Weinheim: Wiley\u2013VCH Verlag GmbH, pp. 33\u201356"},{"issue":"9","key":"9012_CR12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","volume":"64","author":"N.A. Kratochwil","year":"2002","unstructured":"Kratochwil N.A., Huber W., M\u00fcller F., Kansy M., Gerber P.R., 2000 Predicting plasma protein binding of drugs: a new approach Biochem. Pharmacol. 64(9):1355","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"9012_CR13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0134(19981115)33:3<320::AID-PROT2>3.0.CO;2-Q","volume":"33","author":"A.M. Lesk","year":"1998","unstructured":"Lesk A.M., 1998 Extraction of geometrically similar substructures: least-squares and Chebyshev fitting and the difference distance matrix Proteins: Struct., Funct., Genet. 33(3):320","journal-title":"Proteins: Struct., Funct., Genet."},{"issue":"14","key":"9012_CR14","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1021\/jm970732a","volume":"41","author":"H. Kubinyi","year":"1998","unstructured":"Kubinyi H., Hamprecht F.A., Mietzner T., 1998 Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices J. Med. Chem. 41(14):2553","journal-title":"J. Med. Chem."},{"issue":"26","key":"9012_CR15","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1021\/jm970487v","volume":"40","author":"S.S. So","year":"1997","unstructured":"So S.S., Karplus M., 1997 Three-dimensional quantitative structure\u2013activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations J. Med. Chem. 40(26):4347","journal-title":"J. Med. Chem."},{"issue":"26","key":"9012_CR16","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1021\/jm970488n","volume":"40","author":"S.S. So","year":"1997","unstructured":"So S.S., Karplus M., 1997 Three-dimensional quantitative structure\u2013activity relationships from molecular similarity matrixes and genetic neural networks. 2. Applications. J. Med. Chem. 40(26):4360","journal-title":"J.\u2423Med. Chem."},{"issue":"4","key":"9012_CR17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/jm00056a002","volume":"36","author":"A.C. Good","year":"1993","unstructured":"Good A.C., So S.S., Richards W.G., 1993 Structure\u2013activity relationships from molecular similarity matrices J. Med. Chem. 36(4):433","journal-title":"J.\u2423Med. Chem."},{"issue":"3, 4","key":"9012_CR18","first-page":"385","volume":"20","author":"R. Cruz","year":"1997","unstructured":"Cruz R., Lopez N., Quintero M., Rojas G., 1997 Cluster analysis from molecular similarity matrixes using a non-linear neural network J. Math. Chem. 20(3, 4):385","journal-title":"J. Math. Chem."},{"key":"9012_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/9783906390406.ch1","volume-title":"Computer-Assisted Lead Finding and Optimization: Current Tools for Medicinal Chemistry","author":"H. Kubinyi","year":"1997","unstructured":"Kubinyi H., A general view on similarity and QSAR studies. In van de Waterbeemd H., Testa B., Folkers G., Eds.; Computer-Assisted Lead Finding and Optimization: Current Tools for Medicinal Chemistry; VHCA: Basel, and Wiley\u2013VCH: Weinheim, 1997; pp. 7\u201328"},{"key":"9012_CR20","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/ci0100090","volume":"41","author":"J.S. Duca","year":"2001","unstructured":"Duca J.S., Hopfinger A.J., 2001 Estimation of molecular similarity based on 4D-QSAR analysis: formalism and validation J. Chem. Inf. Comput. Sci. 41:1367","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"9012_CR21","volume-title":"Therapeutic Drugs","author":"C. Dollery","year":"1999","unstructured":"Dollery C., Therapeutic Drugs. 2. Churchill Livingstone, Edinburgh: 1999","edition":"2"},{"key":"9012_CR22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jps.2600700602","volume":"70","author":"L.B. Kier","year":"1981","unstructured":"Kier L.B., Hall L.H., 1981 Derivation and significance of valence molecular connectivity J. Pharm. Sci. 70:583","journal-title":"J. Pharm. Sci."},{"key":"9012_CR23","unstructured":"SAS, Version 8.1 for Windows, SAS Institute Inc., 2001"},{"issue":"1\u20133","key":"9012_CR24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"C.A. Lipinski","year":"1997","unstructured":"Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. 1997 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 23(1\u20133):3","journal-title":"Adv. Drug Delivery Rev."},{"key":"9012_CR25","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0957-4166(00)80432-2","volume":"4","author":"A. Seri-Levy","year":"1993","unstructured":"Seri-Levy A., Richards W.G., 1993 Chiral drug potency: Pfeiffer\u2019s rule and computed chirality coefficients Tetrahedron Asymmetry 4:1917","journal-title":"Tetrahedron Asymmetry"},{"key":"9012_CR26","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1021\/jm00037a025","volume":"37","author":"A. Seri-Levy","year":"1994","unstructured":"Seri-Levy A., West S., Richards W.G., 1994 Molecular similarity, quantitative chirality and QSAR for chiral drugs J. Med. Chem. 37:1727","journal-title":"J. Med. Chem."},{"key":"9012_CR27","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/jcc.540111004","volume":"11","author":"C. Burt","year":"1990","unstructured":"Burt C., Huxley P., Richard W.G., 1990 The application of molecular similarity calculations J. Comp. Chem. 11:1139","journal-title":"J. Comp. Chem."},{"key":"9012_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1025309604656","volume":"17","author":"L.M. Hall","year":"2003","unstructured":"Hall L.M., Hall L.H., Kier L.B., 2003 QSAR modeling of \u03b2-lactam binding to human serum proteins J. Comp. Aided Mol. Design 17:103","journal-title":"J. Comp. Aided Mol. Design"},{"key":"9012_CR29","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/ci030019w","volume":"43","author":"L.M. Hall","year":"2003","unstructured":"Hall L.M., Hall L.H., Kier L.B., 2003 Modeling drug albumin binding affinity with E-state topological structure representation J. Chem. Inf. Comput. Sci. 43:2120","journal-title":"J. Chem. Inf. Comput. Sci."}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-005-9012-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-005-9012-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-005-9012-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T16:11:35Z","timestamp":1586535095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-005-9012-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["9012"],"URL":"https:\/\/doi.org\/10.1007\/s10822-005-9012-4","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}